T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.45B |
| 2 |
JPMorgan Chase
JPM
|
+$2.22B |
| 3 |
Atlassian
TEAM
|
+$2.08B |
| 4 |
NVIDIA
NVDA
|
+$1.81B |
| 5 |
Apple
AAPL
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.24B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.08B |
| 3 |
Microsoft
MSFT
|
+$2.68B |
| 4 |
Wells Fargo
WFC
|
+$1.93B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.86B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.79% |
| 2 | Healthcare | 17.19% |
| 3 | Consumer Discretionary | 15.16% |
| 4 | Financials | 10.74% |
| 5 | Communication Services | 10.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Host Hotels & Resorts
HST
$15.6B
| $86.7M | 0.01% |
4,459,574
+1,177,933
| +36% | +$21.3M |
|
777
CDW
CDW
$17.8B
| $86.6M | 0.01% |
484,076
-397,258
| -45% | -$72.7M |
|
778
Agilon Health
AGL
$1.49B
| $86.5M | 0.01% |
136,433
-27,956
| -17% | -$14.4M |
|
|
AVTR.PRA
779
DELISTED
Avantor, Inc. Series A Mandatory Convertible Preferred Stock
AVTR.PRA
| $86.3M | 0.01% |
834,995
-2,150
| -0.3% | -$234K |
|
780
Brady Corp
BRC
$4.43B
| $86.1M | 0.01% |
1,861,195
+4,706
| +0.3% | +$230K |
|
781
Myers Industries
MYE
$1.25B
| $86M | 0.01% |
3,983,440
+652,531
| +20% | +$11.9M |
|
|
HZNP
782
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $85.9M | 0.01% |
816,111
-28,106
| -3% | -$2.74M |
|
783
Iovance Biotherapeutics
IOVA
$2.95B
| $85.9M | 0.01% |
5,156,646
+492,861
| +11% | +$7.62M |
|
784
Cleveland-Cliffs
CLF
$6.93B
| $85.7M | 0.01% |
2,660,134
+1,274,900
| +92% | +$29.1M |
|
785
Shift4
FOUR
$3.79B
| $85.2M | 0.01% |
1,375,810
+1,364,924
| +12,538% | +$72M |
|
|
FORG
786
DELISTED
ForgeRock, Inc.
FORG
| $85.1M | 0.01% |
3,882,685
+695,423
| +22% | +$11.7M |
|
787
Orion
OEC
$360M
| $84.7M | 0.01% |
5,306,778
+737,847
| +16% | +$12.7M |
|
788
CACI
CACI
$14.8B
| $84M | 0.01% |
278,718
+1,494
| +0.5% | +$412K |
|
789
AMN Healthcare
AMN
$1.34B
| $83.8M | 0.01% |
803,602
-1,822
| -0.2% | -$189K |
|
|
FRC
790
DELISTED
First Republic Bank
FRC
| $83.5M | 0.01% |
515,251
+714
| +0.1% | +$125K |
|
791
SLB Ltd
SLB
$77.3B
| $83.2M | 0.01% |
2,014,996
-96,049
| -5% | -$3.77M |
|
792
Dorman Products
DORM
$3.95B
| $82.6M | 0.01% |
869,428
-11,109
| -1% | -$1.08M |
|
793
Cal-Maine
CALM
$3.87B
| $82.5M | 0.01% |
1,494,457
-571,774
| -28% | -$24.9M |
|
794
Essential Properties Realty Trust
EPRT
$6.71B
| $82.3M | 0.01% |
3,253,793
+318,146
| +11% | +$8.19M |
|
|
AESC
795
DELISTED
The AES Corporation
AESC
| $82M | 0.01% |
835,715
+600
| +0.1% | +$54.7K |
|
796
Preferred Bank
PFBC
$1.28B
| $81.7M | 0.01% |
1,102,334
-29,842
| -3% | -$2.31M |
|
797
Embecta
EMBC
$290M
| $81.6M | 0.01% |
+2,448,496
| New | +$101M |
|
798
Winmark
WINA
$1.26B
| $81.2M | 0.01% |
368,955
-3,369
| -0.9% | -$759K |
|
799
IQVIA
IQV
$39.8B
| $80.8M | 0.01% |
349,654
-21,530
| -6% | -$5.1M |
|
800
LPL Financial
LPLA
$29.5B
| $80.8M | 0.01% |
442,314
-42,831
| -9% | -$7.46M |
|
Similar funds
T. Rowe Price Associates's Q1 2022 Portfolio in Review
As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
- T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
- T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
- T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
- T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
- T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.
Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.